Schneeweiss A - Search Results

1

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial.

Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marmé F, Schneeweiss A, Mundhenke C, Distelrath A, Fasching PA, Lux MP, Lüftner D, Hadji P, Janni W, Muth M, Kreuzeder J, Quiering C, Taran FA. Tesch H, et al. Among authors: schneeweiss a. Int J Cancer. 2019 Feb 15;144(4):877-885. doi: 10.1002/ijc.31738. Epub 2018 Oct 30. Int J Cancer. 2019. PMID: 29992557 Free PMC article. Clinical Trial.

2

Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer.

Huober J, Schneeweiss A, Hohaus S, Wittmann G, Meyer A, Martin S, Goldschmidt H, Bastert G, Haas R, Wallwiener D. Huober J, et al. Among authors: schneeweiss a. J Cancer Res Clin Oncol. 1998;124(12):690-4. doi: 10.1007/s004320050233. J Cancer Res Clin Oncol. 1998. PMID: 9879830 Clinical Trial.

3

Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.

Hohaus S, Funk L, Martin S, Schlenk RF, Abdallah A, Hahn U, Egerer G, Goldschmidt H, Schneeweiss A, Fersis N, Kaul S, Wallwiener D, Bastert G, Haas R. Hohaus S, et al. Among authors: schneeweiss a. Br J Cancer. 1999 Mar;79(9-10):1500-7. doi: 10.1038/sj.bjc.6690239. Br J Cancer. 1999. PMID: 10188897 Free PMC article.

4

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer.

Hohaus S, Martin S, Schneeweiss A, Voso MT, Schlenk RF, Wallwiener D, Bastert G, Haas R. Hohaus S, et al. Among authors: schneeweiss a. Cancer Chemother Pharmacol. 1999;44 Suppl:S13-7. doi: 10.1007/s002800051110. Cancer Chemother Pharmacol. 1999. PMID: 10602904 Clinical Trial.

5

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: schneeweiss a. Int J Cancer. 2002 Jul 20;100(3):290-6. doi: 10.1002/ijc.10478. Int J Cancer. 2002. PMID: 12115543

6

Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression.

Schneeweiss A, Sinn HP, Ehemann V, Khbeis T, Neben K, Krause U, Ho AD, Bastert G, Krämer A. Schneeweiss A, et al. Int J Cancer. 2003 Nov 10;107(3):346-52. doi: 10.1002/ijc.11408. Int J Cancer. 2003. PMID: 14506732

7

Induction of remission in a patient with metastatic breast cancer refractory to trastuzumab and chemotherapy following treatment with gefitinib ('Iressa', ZD1839).

Schneeweiss A, Kolay S, Aulmann S, Von Minckwitz G, Torode J, Koehler M, Bastert G. Schneeweiss A, et al. Anticancer Drugs. 2004 Mar;15(3):235-8. doi: 10.1097/00001813-200403000-00007. Anticancer Drugs. 2004. PMID: 15014356

8

Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy.

Schneeweiss A, Katretchko J, Sinn HP, Unnebrink K, Rudlowski C, Geberth M, Beldermann F, Bastert G, Strittmatter HJ. Schneeweiss A, et al. Anticancer Drugs. 2004 Feb;15(2):127-35. doi: 10.1097/00001813-200402000-00005. Anticancer Drugs. 2004. PMID: 15075668

9

Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study.

Schneeweiss A, Huober J, Sinn HP, von Fournier D, Rudlowski C, Beldermann F, Krauss K, Solomayer E, Hamerla R, Wallwiener D, Bastert G. Schneeweiss A, et al. Eur J Cancer. 2004 Nov;40(16):2432-8. doi: 10.1016/j.ejca.2004.08.004. Eur J Cancer. 2004. PMID: 15519516 Clinical Trial.

10

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer.

von Minckwitz G, Jonat W, Fasching P, du Bois A, Kleeberg U, Lück HJ, Kettner E, Hilfrich J, Eiermann W, Torode J, Schneeweiss A. von Minckwitz G, et al. Among authors: schneeweiss a. Breast Cancer Res Treat. 2005 Jan;89(2):165-72. doi: 10.1007/s10549-004-1720-2. Breast Cancer Res Treat. 2005. PMID: 15692759 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

673 results

Search Page

Filters